Key Takeaways
- Cardinal Health (CAH) reported adjusted earnings per share (EPS) of $2.08 for the fourth quarter of fiscal year 2025, exceeding analyst estimates of $2.04.
- Despite the EPS beat, the healthcare services and products company's revenue for the quarter came in at $60.16 billion, falling short of the estimated $60.92 billion.
- Looking ahead, Cardinal Health raised its adjusted EPS guidance for fiscal year 2026 to a range of $9.30 to $9.50, surpassing the consensus analyst estimate of $9.26.
Cardinal Health (CAH) announced its fourth-quarter fiscal year 2025 earnings today, revealing a stronger-than-expected adjusted EPS performance. The company posted adjusted earnings of $2.08 per share, outperforming the analyst consensus estimate of $2.04 per share.
However, the positive EPS surprise was tempered by the company's revenue figures. Cardinal Health reported Q4 2025 revenue of $60.16 billion, which was below the anticipated $60.92 billion. This indicates a mixed financial picture for the quarter, with profitability exceeding expectations despite a slight revenue shortfall.
Looking forward, Cardinal Health provided an optimistic outlook for the upcoming fiscal year. The company raised its adjusted EPS guidance for fiscal year 2026 to a range of $9.30 to $9.50. This revised guidance is notably higher than the analyst estimate of $9.26, suggesting management's confidence in future profitability and operational efficiency. The raised guidance is likely to be a key focus for investors, potentially signaling a positive trajectory for the company's stock.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.